4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-047641
Director sold 2,000 shares at an average $39.39 ($78,771)
- Director acquired 2,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HERSHBERG ROBERT Director | 2020-08-17 | Option exercise | +2,000 | $0.45 | $900 | 2,000 | D |
| HERSHBERG ROBERT Director | 2020-08-17 | Sale | −1,439 | $39.13 | $56,308 | 561 | D |
| HERSHBERG ROBERT Director | 2020-08-17 | Sale | −561 | $40.04 | $22,462 | 0 | D |
| Derivatives | |||||||
| HERSHBERG ROBERT Director | 2020-08-17 | Option exercise · Stock Option (Right to Buy) | −2,000 | 67,000 | D | ||
| Open-market sales · 2,000 sh · avg $39.39 · $78,771 | |||||||
Loading xslF345X03/doc4.xml…